Frequency and significance of granulomas in a cohort of incident cases of Crohn’s disease

Background and aims: Epithelioid granulomas is one of the best histological criterion for distinguishing Crohn’s disease (CD) from other inflammatory bowel diseases. Few data are available on the time of occurrence of epithelioid granulomas, and the value of epithelioid granulomas in predicting outc...

Full description

Saved in:
Bibliographic Details
Published inGut Vol. 54; no. 2; pp. 215 - 222
Main Authors Heresbach, D, Alexandre, J L, Branger, B, Bretagne, J F, Cruchant, E, Dabadie, A, Dartois-Hoguin, M, Girardot, P M, Jouanolle, H, Kerneis, J, Le Verger, J C, Louvain, V, Politis, J, Richecoeur, M, Robaszkiewicz, M, Seyrig, J A
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Society of Gastroenterology 01.02.2005
BMJ Publishing Group LTD
Copyright 2005 by Gut
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background and aims: Epithelioid granulomas is one of the best histological criterion for distinguishing Crohn’s disease (CD) from other inflammatory bowel diseases. Few data are available on the time of occurrence of epithelioid granulomas, and the value of epithelioid granulomas in predicting outcome has been determined only in cohorts of prevalent CD cases. Our objective was to evaluate epithelioid granuloma occurrence in incident CD cases and to examine the associations between epithelioid granulomas and outcome. Patients and methods: We reviewed the histological reports of endoscopic and surgical specimens in a cohort of 188 consecutive incident CD cases seen in 1994 and 1995, and recorded the occurrence of epithelioid granulomas, isolated giant cells, and microgranulomas. Kaplan-Meier curves were plotted for time from CD diagnosis to immunosuppressive treatment or surgery, and associations between epithelioid granulomas and outcome were evaluated in a multivariate analysis. Follow up was at least five years. Results: Granulomas were found in 69 (37%) patients, including 46 (25%) at presentation. Median time from CD diagnosis to epithelioid granuloma detection was 0.16 (0–63) months overall, and 9.59 (0.1–63) months in 23 patients who became epithelioid granuloma positive during follow up. Isolated giant cells were found in 6% of patients and microgranulomas in 12%. Epithelioid granuloma detection increased with the number of endoscopic sampling procedures; sampling site had no influence. By multivariate analysis, epithelioid granulomas were associated with surgical resection but not immunosuppressive therapy. Conclusions: Epithelioid granulomas may separate CD into two pathological subsets and may indicate aggressive disease.
Bibliography:istex:20C5E8A181E8059B347324E1B9712BB4380FA7C8
ark:/67375/NVC-PM770JBH-6
PMID:15647184
local:0540215
Correspondence to:
 Professor D Heresbach
 Service des Maladies de l’Appareil Digestif, Hôpital Pontchaillou, Rue Henri Le Guilloux, 35033-Rennes Cedex, France; denis.heresbach@chu-rennes.fr
href:gutjnl-54-215.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ABERMAD is a non-profit organisation for research on gastrointestinal diseases, affiliated with the Pontchaillou Teaching Hospital, Rennes, France.
Conflict of interest: None declared.
Correspondence to: …Professor D Heresbach …Service des Maladies de l’Appareil Digestif, Hôpital Pontchaillou, Rue Henri Le Guilloux, 35033-Rennes Cedex, France; denis.heresbach@chu-rennes.fr
ISSN:0017-5749
1468-3288
1458-3288
DOI:10.1136/gut.2004.041715